{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T17:42:39Z","timestamp":1774374159077,"version":"3.50.1"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.juro.2006.03.086","type":"journal-article","created":{"date-parts":[[2006,6,29]],"date-time":"2006-06-29T17:44:54Z","timestamp":1151603094000},"page":"559-563","source":"Crossref","is-referenced-by-count":30,"title":["Detectable Prostate Specific Antigen Between 60 and 120 Days Following Radical Prostatectomy for Prostate Cancer: Natural History and Prognostic Significance"],"prefix":"10.1097","volume":"176","author":[{"given":"Shomik","family":"Sengupta","sequence":"first","affiliation":[{"name":"Departments of Urology and Health Sciences Research (Division of Biostatistics), Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl M.","family":"Christensen","sequence":"additional","affiliation":[{"name":"Departments of Urology and Health Sciences Research (Division of Biostatistics), Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Horst","family":"Zincke","sequence":"additional","affiliation":[{"name":"Departments of Urology and Health Sciences Research (Division of Biostatistics), Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey M.","family":"Slezak","sequence":"additional","affiliation":[{"name":"Departments of Urology and Health Sciences Research (Division of Biostatistics), Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley C.","family":"Leibovich","sequence":"additional","affiliation":[{"name":"Departments of Urology and Health Sciences Research (Division of Biostatistics), Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric J.","family":"Bergstralh","sequence":"additional","affiliation":[{"name":"Departments of Urology and Health Sciences Research (Division of Biostatistics), Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert P.","family":"Myers","sequence":"additional","affiliation":[{"name":"Departments of Urology and Health Sciences Research (Division of Biostatistics), Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael L.","family":"Blute","sequence":"additional","affiliation":[{"name":"Departments of Urology and Health Sciences Research (Division of Biostatistics), Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2006.03.086_bib1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000475281","article-title":"Prostate-specific antigen levels after radical prostatectomy and immediate adjuvant hormonal treatment for stage D1 prostate cancer are predictive of early disease outcome","volume":"25","author":"Cheng","year":"1994","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2006.03.086_bib2","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0022-5347(05)66452-X","article-title":"Defining prostate specific antigen progression after radical prostatectomy","volume":"165","author":"Amling","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2006.03.086_bib3","doi-asserted-by":"crossref","first-page":"576","DOI":"10.4065\/76.6.576","article-title":"PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer","volume":"76","author":"Roberts","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.juro.2006.03.086_bib4","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1001\/jama.281.17.1591","article-title":"Natural history of progression after PSA elevation following radical prostatectomy","volume":"281","author":"Pound","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.juro.2006.03.086_bib5","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S1078-1439(03)00103-0","article-title":"Variables in predicting survival based on treating \u201cPSA-only\u201d relapse","volume":"21","author":"Moul","year":"2003","journal-title":"Urol Oncol"},{"key":"10.1016\/j.juro.2006.03.086_bib6","first-page":"127","article-title":"The significance of recurrent PSA after radical prostatectomy","volume":"17","author":"Ravery","year":"1999","journal-title":"Semin Urol Oncol"},{"key":"10.1016\/j.juro.2006.03.086_bib7","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1002\/cncr.20637","article-title":"Natural history of disease progression in patients who fail to achieve an undetectable prostate-specific antigen level after undergoing radical prostatectomy","volume":"101","author":"Rogers","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.juro.2006.03.086_bib8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00005392-200101000-00030","article-title":"Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy","volume":"165","author":"Blute","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2006.03.086_bib9","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0025-6196(12)61218-X","article-title":"Stage C prostatic adenocarcinoma","volume":"64","author":"Nativ","year":"1989","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.juro.2006.03.086_bib10","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1097\/01.ju.0000091876.13656.2e","article-title":"The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy","volume":"170","author":"Ward","year":"2003","journal-title":"J Urol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022534706007828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022534706007828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2006.03.086","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T01:14:20Z","timestamp":1651194860000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2006.03.086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["10.1016\/j.juro.2006.03.086"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2006.03.086","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}